SJS Timeline in California: How to Link Drug Use to Complications

Why timing matters in suspected SJS/TEN

SJS and TEN are severe reactions that can involve skin pain, rash, blistering/skin detachment, and mucous membrane involvement (such as eyes and mouth). They require urgent evaluation and treatment. Medical overviews emphasize that medications are common triggers and that prompt care is critical (see MedlinePlus and NCBI Bookshelf (StatPearls)).

When a drug is suspected, a clear sequence of events helps experts evaluate causation and helps attorneys assess potential liability theories:

• When the medication was started (and any dose changes)
• When the earliest symptoms began (often before a classic rash is documented)
• How quickly symptoms progressed
• When the suspected drug was stopped (if it was)
• When urgent care/ER visits, hospitalization, transfers, and specialty consults occurred

Core documents to build a credible timeline

Medication proof

• Pharmacy dispensing records (fill dates, drug name, strength, quantity, prescriber, and pharmacy location)
• Medication lists from primary care, urgent care, and hospital notes
• Photos of pill bottles/packaging showing manufacturer/labeler info and lot details when available

Medical encounter records

• Urgent care and ER records (triage notes, clinician notes, discharge instructions)
• Hospital admission records, daily progress notes, and consults (especially dermatology and ophthalmology)
• Pathology/biopsy reports (if performed)
• Transfer records (for example, transfer to a burn center)

Visual evidence

• Dated photographs showing progression (skin findings, mouth sores, eye involvement)
• Copies of inpatient wound photos if available

Complication and follow-up records

• Ophthalmology records (dry eye, corneal injury, vision changes)
• Gynecology/urology records (scarring, pain, strictures)
• Pulmonary records (persistent respiratory symptoms)
• Mental health records (anxiety, depression, PTSD symptoms after hospitalization)

How experts often evaluate drug causation

No single document proves causation by itself. Experts typically weigh multiple factors such as timing, alternative causes, and known drug-risk information. One published method used in SJS/TEN drug-causality assessment is ALDEN (see Sassolas et al., 2010 (PubMed)).

• Temporal relationship: whether symptoms began after starting (or changing) a medication and whether the course fits a severe drug reaction.
• Dechallenge: whether the suspect drug was stopped and how the course evolved. Rechallenge is generally inappropriate in suspected SJS/TEN due to safety risk.
• Alternative causes: whether infections, autoimmune disease, malignancy, or other drugs could explain the reaction.
• Known association: whether labeling/safety sources recognize SJS/TEN as a potential adverse reaction (see FDA: Drug Safety and Availability and clinical summaries like NCBI Bookshelf (StatPearls)).

Complications to document

Medical references describe SJS/TEN as capable of causing acute complications and longer-term sequelae, particularly involving the eyes and mucous membranes (see MedlinePlus and NCBI Bookshelf (StatPearls)).

• Eyes: chronic dry eye, corneal injury, scarring, vision changes
• Skin: pigment changes, scarring, nail changes, chronic pain
• Mucosa: oral lesions affecting nutrition; genital/urinary scarring and pain
• Systemic: infections and other inpatient complications; persistent fatigue or respiratory symptoms
• Functional/economic: time off work, reduced daily activities, need for caregiving
• Psychological: anxiety, depression, PTSD symptoms

California legal angles that may be evaluated (fact-dependent)

Whether a viable claim exists depends on the facts, medical records, and expert review. In California, attorneys evaluating suspected drug-induced SJS/TEN sometimes analyze:

• Pharmaceutical product liability (often failure-to-warn focused): see Carlin v. Superior Court (1996) 13 Cal.4th 1104.
• Design-defect limits for prescription drugs: see Brown v. Superior Court (1988) 44 Cal.3d 1049 (analysis can be nuanced and fact-dependent).
• Medical negligence: prescribing decisions, counseling on warning signs, monitoring/follow-up, and whether delays in recognition or stopping a drug worsened outcomes.
• Pharmacy issues (case-specific): dispensing errors or documentation issues that warrant investigation.

Deadlines: Limitations periods can vary. California’s general personal-injury limitations period is two years (see Cal. Civ. Proc. Code § 335.1). Medical malpractice claims have special timing rules (see Cal. Civ. Proc. Code § 340.5). Claims involving public entities may require earlier claim presentation (see Cal. Gov. Code § 911.2).

FAQ

What if I do not remember exactly when I started the medication?

Request your pharmacy dispensing history (including all pharmacies used). It often provides the most reliable dates for start windows, refills, and prescribers.

What if the first doctor visit did not mention SJS/TEN?

That is common. Early symptoms may be recorded as viral-like illness or nonspecific rash before later documentation identifies suspected SJS/TEN. Preserve records from every visit.

Do I need photos?

Photos can help show progression, but they are not required. If you have them, keep the originals and avoid edits so timestamps/metadata are preserved when possible.

Can more than one drug be responsible?

Yes. Experts often review all medications started in the relevant window, including short courses (like antibiotics) and over-the-counter products.

When should I talk to a California attorney?

As soon as you are medically stable and can gather records. Early review can help identify what records to request and what deadlines may apply. Contact us to discuss your situation.

Call to action: If you want help organizing a California SJS/TEN timeline for expert review, schedule a consultation here.